Kieseier B C, Paul R, Koedel U, Seifert T, Clements J M, Gearing A J, Pfister H W, Hartung H P
Department of Neurology, Karl-Franzens-Universität, Graz, Austria, Department of Neurology, Ludwig-Maximilians-Universität, München, Germany.
Brain. 1999 Aug;122 ( Pt 8):1579-87. doi: 10.1093/brain/122.8.1579.
Matrix metalloproteinases (MMPs) are implicated in the pathogenesis of various inflammatory diseases of the central nervous system. Evidence is accumulating that gelatinase B (MMP-9) might be involved in the pathogenesis of meningitis, but the spectrum of different MMPs involved in the inflammatory reaction of this disease has not been determined. We investigated the temporal and spatial mRNA expression pattern of gelatinase B in experimental meningococcal meningitis in rats. In contrast to controls, increased mRNA levels with peak values 6 h after injection with menigococci were found in brain specimens of the animals. Elevated MMP-9 mRNA expression was accompanied by enhanced proteolytic activity, as demonstrated by gelatin zymography, and positive immunoreactivity. The mRNA expression pattern of six other MMPs was investigated. Collagenase-3 and stromelysin-1 mRNAs were also found to be upregulated. In contrast, mRNA levels for gelatinase A, matrilysin, stromelysin-2 and stromelysin-3 remained unchanged. As evidenced by significantly increased intracranial pressure and by leakage of intravenously injected Evans blue through the blood vessel walls into the brain parenchyma, the animals injected with meningococci revealed signs of blood-brain barrier disruption. Augmented proteolytic activity of MMP-9 could also be demonstrated in CSF samples obtained from patients with bacterial meningitis, underlining the clinical relevance of our experimental findings. Our data indicate that gelatinase B, collagenase-3 and stromelysin-1 are selectively upregulated in bacterial meningitis and thus may contribute to the pathogenesis of this infectious disease of the central nervous system.
基质金属蛋白酶(MMPs)与中枢神经系统各种炎症性疾病的发病机制有关。越来越多的证据表明,明胶酶B(MMP - 9)可能参与脑膜炎的发病机制,但该疾病炎症反应中涉及的不同MMPs谱尚未确定。我们研究了大鼠实验性脑膜炎球菌性脑膜炎中明胶酶B的时空mRNA表达模式。与对照组相比,在注射脑膜炎球菌后6小时达到峰值的动物脑标本中发现mRNA水平升高。如明胶酶谱所示,MMP - 9 mRNA表达升高伴随着蛋白水解活性增强和阳性免疫反应性。研究了其他六种MMPs的mRNA表达模式。还发现胶原酶 - 3和基质溶解素 - 1的mRNA上调。相比之下,明胶酶A、基质溶素、基质溶解素 - 2和基质溶解素 - 3的mRNA水平保持不变。注射脑膜炎球菌的动物颅内压显著升高,静脉注射的伊文思蓝通过血管壁渗漏到脑实质中,这表明存在血脑屏障破坏的迹象。在细菌性脑膜炎患者的脑脊液样本中也证实了MMP - 9蛋白水解活性增强,这突出了我们实验结果的临床相关性。我们的数据表明,明胶酶B、胶原酶 - 3和基质溶解素 - 1在细菌性脑膜炎中选择性上调,因此可能有助于这种中枢神经系统感染性疾病的发病机制。